![PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/473da07f05acbc0faf8cfff7211cb3844b39f688/4-Table2-1.png)
PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar
![Comparison between levels of tumor markers in serum and ascetic fluid... | Download Scientific Diagram Comparison between levels of tumor markers in serum and ascetic fluid... | Download Scientific Diagram](https://www.researchgate.net/publication/257132271/figure/tbl1/AS:1003079608582144@1616164223000/Comparison-between-levels-of-tumor-markers-in-serum-and-ascetic-fluid-among-patients.png)
Comparison between levels of tumor markers in serum and ascetic fluid... | Download Scientific Diagram
![PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6824ffeb999b927b99ef8b3b3ec2a4cc9987909e/4-Table2-1.png)
PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment | PLOS ONE
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy | Scientific Reports Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-57540-7/MediaObjects/41598_2020_57540_Fig1_HTML.png)
Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy | Scientific Reports
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356519312388-gr1.jpg)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
![Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case | npj Precision Oncology Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-022-00289-1/MediaObjects/41698_2022_289_Fig1_HTML.png)
Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case | npj Precision Oncology
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study](https://www.mdpi.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg)